Dermatophytoses: Taxonomy, Pathogenesis, Diagnosis, Resistance, and Management.

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 3 | 01 | Page :
    By

    Pradeep singh 1 *,

  • Atul Khajuria1,

  • Ashish Kumar 2,

  1. Faculty, department of Allied & Health Care Sciences, Rayat Bahra Professional University, Hoshiarpur, Punjab, India
  2. Dean, department of Allied & Health Care Sciences, Rayat Bahra Professional University, Hoshiarpur, Chandigarh Rd, VPO, Bohan, Hoshiarpur, punjab, India
  3. Faculty, Department of Allied & Health Care Sciences, Rayat Bahra Professional University Hoshiarpur – Chandigarh Rd, VPO, Bohan, Hoshiarpur, punjab, India

Abstract

Dermatophytes, belonging to the family Arthrodermataceae, are keratinophilic fungi responsible for superficial mycoses. Dermatophytoses affect the skin, hair, and nails globally. Over the last few years, dermatophytic infections have seen a sharp rise in India, with the main causative agent being antifungal-resistant Trichophyton mentagrophytes genotype VIII. This review provides a detailed overview of dermatophytoses, including taxonomy, pathogenesis, epidemiology, diagnosis, and treatment. Dermatophytes belong to the kingdom Fungi, family Arthrodermataceae, with seven different species, including Trichophyton, Nannizzia, and Epidermophyton. Dermatophytes cause infection by the adhesion of arthroconidia to keratinized tissues followed by invasion via the production of keratinases. Dermatophytoses present with different manifestations, with the majority being tinea corporis (32.4%), followed by tinea cruris (19.7%), onychomycosis (17.9%), and tinea capitis (13.3%) in the Indian population. Epidemiologically, the infections were previously caused by Trichophyton rubrum, which is now being replaced by antifungal-resistant Trichophyton
mentagrophytes, responsible for 64% cases. Factors contributing to the epidemiological shift include the widespread misuse of topical corticosteroids, the prevalence of diabetes mellitus, and the effects of COVID-19. Potassium hydroxide (KOH) microscopy is the diagnostic tool with the highest sensitivity, ranging from 70 to 90%, followed by culture and internal transcribed spacer polymerase chain reaction with 95 to 99% sensitivity. However, the main drawback is the high resistance to terbinafine, with mutations in the squalene epoxidase (SQLE) gene, including Leu393Phe and Ala448Thr mutations, seen in 50 to 65% cases in the Indian population. Terbinafine is the drug of choice, with oral terbinafine being the first-line treatment with cure rates ranging from 70 to 90%, although the widespread resistance to terbinafine is the biggest drawback in the treatment of dermatophytoses. Combination therapy is required to overcome the resistance. Prevention is simple, with emphasis on personal hygiene and avoidance of fomites.

Keywords: Keywords: Dermatophytes, Trichophyton mentagrophytes, Antifungal resistance, Dermatophytosis, Terbinafine.

How to cite this article:
Pradeep singh 1 *, Atul Khajuria1, Ashish Kumar 2. Dermatophytoses: Taxonomy, Pathogenesis, Diagnosis, Resistance, and Management.. International Journal of Fungi. 2026; 03(01):-.
How to cite this URL:
Pradeep singh 1 *, Atul Khajuria1, Ashish Kumar 2. Dermatophytoses: Taxonomy, Pathogenesis, Diagnosis, Resistance, and Management.. International Journal of Fungi. 2026; 03(01):-. Available from: https://journals.stmjournals.com/ijf/article=2026/view=239724


References

1. de Hoog GS, Dukik K, Monod M, et al. Towards a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycoses. 2017;60(3):240-56.
2. Rudramurthy SM, Singh A, Dogra S, et al. Extensively terbinafine-resistant Trichophyton mentagrophytes in India: emergence of a resistant genotype VIII strain.
J Clin Microbiol. 2021;59(5):e02504-20.
3. Verma SB, Gk G, Vasani R, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features. Indian J
Dermatol Venereol Leprol. 2021;87(3):330-7.
4. Nenoff P, Krüger C, Schaller J, et al. Mycology – an update part 2: dermatomycoses: clinical picture and diagnostics. J Dtsch Dermatol Ges. 2015;13(9):920-43.
5. Hay RJ. Dermatophytosis (ringworm) and other superficial mycoses. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Elsevier; 2020:3105-17.
6. Pathania S, Budhiraja V, Neena, et al. Is the new variety of Trichophyton mentagrophytes responsible for the current epidemic of dermatophytosis in north
India? Med Mycol Case Rep. 2018;22:29-32.
7. Singh A, Yashika, Rudramurthy SM, et al. A prospective multicentre study of Trichophyton indotineae infections in India: experience from eight centres. Mycoses.
2020;63(7):771-6.
8. Hryncewicz-Gwóźdź A, Gnat S, Nowakiewicz A, et al. Molecular identification and classification of Trichophyton mentagrophytes complex strains. Diagn Microbiol
Infect Dis. 2019;93(1):73-9.
9. Kano R, Okubo M, Nakayama S, et al. Mutations in the squalene epoxidase gene of terbinafine-resistant Trichophyton mentagrophytes. Antimicrob Agents Chemother.
2018;62(5):e02538-17.
10. Saunte DM, Piraccini BM, Tarau L, et al. The year in review 2021: onychomycosis and its treatment. J Fungi (Basel). 2022;8(3):264.
11. Zhan P, Li Z, Geng C, et al. Molecular epidemiology of Trichophyton mentagrophytes complex isolates from patients with tinea cruris in India. Mycoses.
2021;64(8):1002-9.
12. Singh A, Rudramurthy SM, Dogra S, et al. Prevalence and antifungal susceptibility profile of Trichophyton indotineae in North India. Clin Microbiol Infect.
2022;28(6):862.e1-862.e5.
13. Gehi JS, Dhamale M, Fernandes M, et al. Clinicomycological profile of dermatophytosis in Mumbai, India. Int J Dermatol. 2020;59(5):567-72.
14. Dash K, Dash SK, Swain P, et al. Antifungal resistance in dermatophytes: recent trends and therapeutic implications. Fungal Genet Biol. 2021;155:101599.
15. Elewski BE, Hughey LC, Sobera JO, et al. Fungal diseases of the skin. In: Kang S, Amagai M, Bruckner AL, et al., eds. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill; 2019:3165-92.
16. Marolda R, De Hoog GS, Dukik K, et al. Updating the taxonomy of dermatophytes of the BCCM/IHEM collection. J Fungi (Basel). 2019;5(4):114.
17. de Hoog GS, Monod M, Dawson T, et al. Current topics in dermatophyte classification and clinical diagnosis. J Fungi (Basel). 2022;8(9):901.
18. Hay RJ. Dermatophytes: update on clinical epidemiology and treatment. Curr Opin
Infect Dis. 2024;37(6):492-7.
19. Singh A, Dogra S, Rudramurthy SM, et al. Rising incidence of Trichophyton indotineae in India: molecular epidemiology and antifungal susceptibility. Lancet
Microbe. 2023;4(5):e330-1.
20. Gk G, Verma SB, Vasani R, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: II. Diagnostic methods and taxonomical aspects. Indian J
Dermatol Venereol Leprol. 2021;87(4):460-70.
21. Nenoff P, Krüger C, Schaller J, et al. Mycology – an update part 3: therapy. J Dtsch Dermatol Ges. 2015;13(10):979-1008.
22. Rudramurthy SM, Chakrabarti A, Dogra S, et al. Emerging antifungal resistance in dermatophytosis. Indian J Med Res. 2025;162(3):225-35.
23. Ashbee HR, Evans EGV, Viviani MA, et al. Therapeutic strategies for superficial dermatophytoses: focus on azoles. J Eur Acad Dermatol Venereol. 2002;16(5):427-
35.
24. Gupta AK, Foley KA, Versteeg SG. New antifungal agents and novel therapeutic approaches for onychomycosis. Expert Rev Anti Infect Ther. 2017;15(2):199-212.
25. Monod M, Méhul B. Recent findings in molecular biology and immunology of dermatophyte infections. Curr Opin Microbiol. 2021;62:1-7.
26. Dogra S, Singh A, Rudramurthy SM, et al. Alarming India-wide phenomenon of antifungal resistance in dermatophytes: a multicentre study. Mycoses.
2020;63(7):717-25.
27. Hiruma J, Hiruma M, Kawada A, et al. Deep dermatophytosis: a case report of Majocchi granuloma due to Trichophyton rubrum. J Dermatol. 2012;39(9):844-6.
28. Patel VR, Dharamsi J, Singla K, et al. Insights into changing dermatophyte spectrum in India: T. mentagrophytes genotype VIII dominates. Indian J Dermatol Venereol Leprol. 2023;89(2):189-96.
29. Rossanese M, de Hoog GS, Dukik K, et al. Phylogeny of dermatophytes with genomic data supports seven genera. Mycopathologia. 2020;185(5):729-43.
30. Kano R, Murai T, Hasegawa A, et al. Molecular epidemiology of Arthroderma benhamiae infection in pet guinea pigs in Japan. Med Mycol. 2008;46(5):481-4.
31. Das S, De A, Sil A, et al. A study on causative agents and sensitivity patterns of dermatophytosis in a tertiary care hospital in South Kolkata. Indian J Dermatol.
2020;65(1):47-51.
32. Dhawan V, Gupta P, Singh PK, et al. Clinicomycological profile of dermatophyte infections at a tertiary care hospital from South India. Indian J Dermatol Venereol
Leprol. 2023;89(4):512-8.
33. Singh G, Cevallos ME, Kerchner JA, et al. The rise of antifungal-resistant dermatophyte infections: what dermatologists need to know. J Am Acad Dermatol.
2025;92(5):1023-30.
34. Khurana S, Meena D, Chowdhary A, et al. Burden of serious fungal infections in India. Open Forum Infect Dis. 2022;9(12):ofac603.
35. Urban K, Lemmer D, Naujokat H, et al. Terbinafine resistance of Trichophyton mentagrophytes/Trichophyton interdigitale complex due to squalene epoxidase
(SQLE) gene mutations. J Eur Acad Dermatol Venereol. 2021;35(11):e801-4.
36. Drouot S, Schwarz T, Dittmer S, et al. In vitro antifungal susceptibility of Trichophyton mentagrophytes/Trichophyton interdigitale species complex from a
global dermatophyte surveillance program. J Clin Microbiol. 2023;61(4):e0178622.
37. Gupta AK, Summers A, Versteeg SG, et al. Antifungal resistance in dermatophytes: mechanisms, diagnosis, and management strategies. J Fungi (Basel). 2023;9(2):181.
38. Hay RJ, Ashbee HR. Mycology. In: Griffiths CEM, Barker J, Bleiker TO, et al., eds. Rook’s Textbook of Dermatology. 9th ed. Oxford: Wiley-Blackwell; 2021:1-118.
39. White TC, Oliver BG, Graser Y. Genotyping and antifungal susceptibility of Trichophyton mentagrophytes isolated from patients with tinea pedis in Germany.
Med Mycol. 2008;46(4):325-32.
40. Mochizuki T, Kawasaki H, Ishizaki H, et al. Molecular epidemiology of Arthroderma vanbreuseghemii isolates from humans and animals. J Vet Med Sci. 2001;63(9):1023-7.
41. Jackson CJ, Mochizuki T, Barton R. PCR fingerprinting of Trichophyton mentagrophytes var. interdigitale using non-transcribed spacers of ribosomal DNA as
strain markers. J Clin Microbiol. 2000;38(10):3827-30.
42. Summerbell RC, Lévesque CA, Seifert KA, et al. Taxonomic re-evaluation of Trichophyton mentagrophytes var. interdigitale and its relationship to T.
mentagrophytes var. mentagrophytes. Mycoses. 1993;36(5-6):197-204.
43. Brouta C, Monod M, Senet JM, et al. Secreted metalloprotease gene family of Trichophyton rubrum. Gene. 2001;265(1-2):37-46.
44. Jousson O, Jou Tabib S, Steiner S, et al. Dermatophytes and host tree evolution: a test with Microsporum spp. isolates from South American tree hollows. Fungal Genet Biol. 2004;41(10):1015-23.
45. Symoens F, Jousson O, Packeu A, et al. Trehalose synthase of Trichophyton rubrum. BMC Microbiol. 2013;13:48.

Ahead of Print Subscription Review Article
Volume 03
01
Received 31/03/2026
Accepted 31/03/2026
Published 04/04/2026
Publication Time 4 Days
40

Login


My IP

PlumX Metrics